Coronary artery disease
Conditions
Interventions
None listed
Sponsors
Department of Cardiology, National Hospital Organization Kyushu Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) more than 20 years old 2) suitable lesion for drug-eluting stent implantation in the LM 3) de novo lesion 4) tolerable for dual antiplatelet therapy for more than 6 months 5) LMPCI performed in the NHO group from January 1, 2016 to December 31, 2020
Exclusion criteria
Exclusion criteria: 1) In-stent restenotic lesion 2) Chronic total occlusion 3) Left anterior descending artery and/or circumflex artery are protected by prior coronary bypass surgery 4) Female with possible or definite pregnancy 5) Unsuitable candidate judged by the responsible doctor 6) Rejection for the recruitment of personal information to the study after the notice of the study information according to the opt-out system
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major adverse cerebro- and cardio-vascular events (MACCE) defined as composite endpoints of all cause of death, cerebrovascular disorder, myocardial infarction and clinical driven revascularization at 3-year follow-up after the LM PCI | — |
Secondary
| Measure | Time frame |
|---|---|
| Cumulative occurrence of MACCE and each event at discharge, 1-year, 2-year and 3-year follow-up | — |
Countries
Japan
Contacts
Public ContactYoshinobu Murasato
National Hospital Organization Kyushu Medical Center Department of Cardiology
Outcome results
None listed